Thomas P W, Thomas S, Hillier C, Galvin K, Baker R
Poole Hospital NHS Trust, Dorset Research and Development Support Unit, Cornelia House, Longfleet Road, Poole, Dorset, UK, BH15 2JB.
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD004431. doi: 10.1002/14651858.CD004431.pub2.
The unpredictable, variable nature of Multiple Sclerosis (MS), and the possibility of increasing disability, means that a diagnosis can have substantial psychological consequences.
To assess the effectiveness of psychological interventions for people with MS.
We searched 19 databases up to December 2004; Cochrane MS Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, PsychINFO, CINAHL and 14 others. We searched reference lists of articles, wrote to corresponding authors of the 13 papers identified by June 2004, and searched for trials in progress using 3 research registers.
Randomised controlled trials of interventions described as wholly or mostly based on psychological theory and practice, in people with MS. Primary outcome measures were disease specific and general quality of life, psychiatric symptoms, psychological functioning, disability, and cognitive outcomes. Secondary outcome measures were number of relapses, pain, fatigue, health care utilisation, changes in medication, and adherence to other therapies.
Pertinent studies were identified from abstracts by one author. Full papers were independently compared to selection criteria by four authors. Key details were extracted from relevant papers using a standard format, and studies scored on three dimensions of quality. The review is organised into four mini-reviews (MR) dependent on the intervention's target population; people with cognitive impairments (MR1), people with moderate to severe disability (MR2), people with MS (no other criteria) (MR3), and people with depression (MR4).
Overall 16 studies were identified and included. MR1: three trials (n=145). Some evidence of effectiveness of cognitive rehabilitation on cognitive outcomes, although this was difficult to interpret because of the large number of outcome measures used. MR2: three trials (n=80). One small trial suggesting psychotherapy may help with depression. MR3: seven studies (n=688). Some evidence that cognitive behavioural therapy may help people adjust to, and cope with, having MS (three trials). The other trials were diverse in nature and some difficult to interpret because of multiple outcome measures. MR4: three trials (n=93). Two small studies of cognitive behavioural therapy showed significant improvements in depression.
AUTHORS' CONCLUSIONS: The diversity of psychological interventions identified indicates the many ways in which they can potentially help people with MS. No definite conclusions can be made from this review. However there is reasonable evidence that cognitive behavioural approaches are beneficial in the treatment of depression, and in helping people adjust to, and cope with, having MS.
多发性硬化症(MS)具有不可预测、多变的特性,且存在残疾加剧的可能性,这意味着确诊可能会带来重大的心理影响。
评估针对MS患者的心理干预措施的有效性。
截至2004年12月,我们检索了19个数据库;Cochrane MS小组专业注册库、Cochrane对照试验中央注册库(CENTRAL)、医学期刊数据库(MEDLINE)、心理学文摘数据库(PsychINFO)、护理学与健康领域数据库(CINAHL)以及其他14个数据库。我们检索了文章的参考文献列表,给2004年6月前确定的13篇论文的通讯作者写信,并通过3个研究注册库搜索正在进行的试验。
针对MS患者的、描述为完全或主要基于心理学理论与实践的干预措施的随机对照试验。主要结局指标为疾病特异性和总体生活质量、精神症状、心理功能、残疾状况以及认知结果。次要结局指标为复发次数、疼痛、疲劳、医疗保健利用情况、药物变化以及对其他治疗的依从性。
由一位作者从摘要中识别相关研究。四位作者将全文独立与入选标准进行比较。使用标准格式从相关论文中提取关键细节,并根据质量的三个维度对研究进行评分。该综述根据干预的目标人群分为四个小型综述(MR);认知障碍患者(MR1)、中度至重度残疾患者(MR2)、MS患者(无其他标准)(MR3)以及抑郁症患者(MR4)。
共识别并纳入16项研究。MR1:三项试验(n = 145)。有一些证据表明认知康复对认知结果有效,不过由于使用的结局指标众多,难以进行解读。MR2:三项试验(n = 80)。一项小型试验表明心理治疗可能有助于缓解抑郁。MR3:七项研究(n = 688)。有一些证据表明认知行为疗法可能有助于人们适应并应对MS(三项试验)。其他试验性质各异,由于多个结局指标,有些难以解读。MR4:三项试验(n = 93)。两项关于认知行为疗法的小型研究显示抑郁有显著改善。
所识别的心理干预措施的多样性表明了它们潜在帮助MS患者的多种方式。本综述无法得出明确结论。然而,有合理证据表明认知行为方法在治疗抑郁症以及帮助人们适应并应对MS方面有益。